You are here: Industry Insights > Sterling

News List

Sterling Pharma Solutions Appoints Ian Baxendale to Lead Team at Dudley, UK Site contractpharma
July 30, 2021
Baxendale has over 20 years of academic and industrial experience within organic synthesis.
Sterling Pharma Appoints Stewart Mitchell as New Site Head contractpharma
May 25, 2021
Sterling Pharma Solutions, a global CDMO, has appointed Stewart Mitchell as site head of its new antibody-drug conjugate (ADC) facility in Deeside, UK. Dr. Mitchell will lead the Deeside facility, and report to Kevin Cook ...
OncoTEX, Sterling Pharma Sign Clinical Mfg. Pact contractpharma
May 11, 2021
Sterling will produce clinical material for OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX, for use in clinical trials.
FDA Approves ADC Therapeutics' Zynlonta contractpharma
May 08, 2021
ADC collaborated with CDMO Sterling Pharma Solutions to develop the cancer drug.
Sterling Pharma Solutions Acquires ADC Biotechnology contractpharma
April 08, 2021
Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has acquired ADC Biotechnology, a UK-based bioconjugation development services business specializing in antibody drug conjugates (ADCs).
Sterling Makes Strategic Investment in ADC Bio contractpharma
December 03, 2020
Sterling Pharma Solutions, a global CDMO, has entered a new strategic partnership with ADC Biotechnology, a UK company specializing in antibody drug conjugates.
Sterling Starts Large-scale Production of Nanologica’s Silica Particles contractpharma
August 29, 2019
First commercial batch is expected to be delivered during 2021.
Sterling’s Pilot Plant Facility Expansion is Operational contractpharma
June 05, 2019
CDMO now has capability to handle potent compounds across a range of equipment scales.
Sterling Expands API Capabilities contractpharma
October 25, 2017
nvests £6 million to strengthen and expand its milling, micronization and solid form capabilities